Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy
Authors
Keywords
-
Journal
INFECTION
Volume 39, Issue 4, Pages 333-340
Publisher
Springer Nature
Online
2011-06-26
DOI
10.1007/s15010-011-0132-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk Factors in Community-Acquired/Onset Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase-ProducingEscherichia coliandKlebsiella pneumoniae
- (2014) E. Yilmaz et al. JOURNAL OF CHEMOTHERAPY
- Executive Summary: International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
- (2011) Kalpana Gupta et al. CLINICAL INFECTIOUS DISEASES
- Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum- -Lactamase-Producing Escherichia coli
- (2010) S. Auer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact
- (2010) Jesús Oteo et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Risks Factors for Infections with Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae at a Tertiary Care University Hospital in Switzerland
- (2010) S. P. Kuster et al. INFECTION
- Current therapy of acute uncomplicated cystitis
- (2010) Shingo Yamamoto et al. INTERNATIONAL JOURNAL OF UROLOGY
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients
- (2009) Ronen Ben‐Ami et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections
- (2009) Ö.K. Azap et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prospective Evaluation of Colonization with Extended-Spectrum β-Lactamase (ESBL)–Producing Enterobacteriaceae Among Patients at Hospital Admission and of Subsequent Colonization with ESBL-Producing Enterobacteriaceae Among Patients During Hospitalization
- (2009) Reuven Friedmann et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
- (2009) Matthew E Falagas et al. LANCET INFECTIOUS DISEASES
- Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
- (2008) Jesús Rodríguez-Baño et al. ARCHIVES OF INTERNAL MEDICINE
- Defining an extended-spectrum β-lactamase
- (2008) D.M. Livermore CLINICAL MICROBIOLOGY AND INFECTION
- Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: Importance of international travel
- (2008) Kevin B. Laupland et al. JOURNAL OF INFECTION
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
- (2008) Johann DD Pitout et al. LANCET INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started